Anal cancer prevention for high-risk men who have sex with men
Part of Immune system & allergy, Infections clinical trials.
This trial tests a prevention program for anal cancer in men who have sex with men who are at higher risk, such as those with HIV or taking PrEP. It aims to find and treat early signs of anal cancer to stop it from developing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man who has sex with men.
- You are 35 years or older.
- You have HIV or are HIV-negative and taking PrEP.
- You are willing to have an anal exam called high-resolution anoscopy (HRA).
- You have not had anal cancer before, and you do not have inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a probiotic called EXE-346 can help clear anal high-grade squamous intraepithelial lesions (HSIL), a precancerous condition, in people with HIV who are on effective antiretroviral therapy. If you have anal HSIL that wasn't fully removed by biopsy, you may be able to join.
This trial tests an artesunate ointment to treat high-grade anal precancer (HSIL) in people who do not have HIV. The goal is to see if the ointment can clear the abnormal cells caused by HPV.
This study is screening gay and bisexual men for anal cancer by taking a swab sample. It aims to find early signs of cancer so it can be treated early.
This study looks at using a simple swab to screen for HPV (the virus that can cause anal cancer) in people living with HIV. By collecting a sample from the anal area, the study aims to find a less invasive way to check for risk, helping you avoid more uncomfortable procedures unless needed.
This study tests whether having people collect their own anal samples at home can help find and treat early signs of anal cancer. It is for men and transgender women who have sex with men and who live in or near Chicago, Houston, or Milwaukee.
This study is looking at ways to screen for anal cancer in people who are at higher risk, such as those with weakened immune systems or a history of abnormal cells in the lower genital tract. It aims to find better methods for early detection.
Hear when a new Anal HSIL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.